These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9169645)

  • 21. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
    Chen G; Shao Z; Jia H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
    Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
    Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recovery of marrow myeloid progenitors (CFU-GM) after bone marrow transplantation, especially associated with chronic graft-versus-host disease (GVHD)].
    Takatsu H; Hirokawa M; Oshima A; Miura I; Niitsu H; Takahashi T; Yoshida K; Endo Y; Miura AB
    Rinsho Ketsueki; 1989 Apr; 30(4):460-5. PubMed ID: 2671438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
    Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
    Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incomplete stroma formation after allogeneic marrow or autologous blood stem cell transplantation.
    Rice A; Reiffers J; Bernard P; Fourès C; Bascans E; Lacombe F; Marit G; Broustet A
    Nouv Rev Fr Hematol (1978); 1992; 34(2):167-74. PubMed ID: 1354352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconstitution of the CD45RO(+) and CD20(+) lymphoid marrow population following allogeneic bone marrow transplantation for Ph(+) CML.
    Thiele J; Kvasnicka HM; Beelen DW; Welter A; Schneider S; Leder LD; Schaefer UW
    Bone Marrow Transplant; 2001 Feb; 27(4):425-31. PubMed ID: 11313672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Kröger N; Krüger W; Wacker-Backhaus G; Hegewisch-Becker S; Stockschläder M; Fuchs N; Rüssmann B; Renges H; Dürken M; Bielack S; de Wit M; Schuch G; Bartels H; Braumann D; Kuse R; Kabisch H; Erttmann R; Zander AR
    Bone Marrow Transplant; 1998 Dec; 22(11):1029-33. PubMed ID: 9877263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in the progenitor cell population follow recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohammed R
    Exp Hematol; 1997 Jun; 25(6):471-7. PubMed ID: 9197323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation.
    Tayebi H; Tiberghien P; Ferrand C; Lienard A; Duperrier A; Cahn JY; Lapierre V; Saas P; Kuentz M; Blaise D; Hervé P; Robinet E;
    Bone Marrow Transplant; 2001 Jan; 27(2):167-75. PubMed ID: 11281386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.
    Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS
    Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
    Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
    Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study.
    Scott MA; Gandhi MK; Jestice HK; Mahendra P; Bass G; Marcus RE
    Bone Marrow Transplant; 1998 Aug; 22(3):273-6. PubMed ID: 9720741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia.
    Morariu-Zamfir R; Rocha V; Devergie A; Socié G; Ribaud P; Esperou H; Parquet N; Guardiola P; Dal Cortivo L; Bittencourt H; Garnier F; Traineau R; Marolleau JP; Chevret S; Gluckman E
    Bone Marrow Transplant; 2001 Mar; 27(6):575-80. PubMed ID: 11319585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.